Testing effectiveness (Phase 2)Ended earlyNCT04434560What this trial is testingNeoadjuvant Immunotherapy in Brain MetastasesWho this might be right forBrain Metastases, Adult Sarah Sammons, MD 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05821686What this trial is testingEfficacy of Interleukin-2 in Triple Negative Breast CancerWho this might be right forTriple Negative Breast Cancer Nova Scotia Health Authority 10
Testing effectiveness (Phase 2)Looking for participantsNCT06827613What this trial is testingInvikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid TumorsWho this might be right forTriple Negative Locally Advanced Non-resectable Breast CancerHR+, HER2-, Advanced Breast Cancer Marengo Therapeutics, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00951054What this trial is testingNK012 in Patients With Advanced, Metastatic Triple Negative Breast CancerWho this might be right forTriple Negative Breast Cancer Nippon Kayaku Co., Ltd. 61
Large-scale testing (Phase 3)Not Yet RecruitingNCT04301739What this trial is testingTo Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)Who this might be right forTriple Negative Breast Cancer Shanghai Henlius Biotech 522
Testing effectiveness (Phase 2)Active Not RecruitingNCT03546686What this trial is testingPeri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast CancerWho this might be right forBreast Cancer University of Texas Southwestern Medical Center 51
Testing effectiveness (Phase 2)Ended earlyNCT03979508What this trial is testingAbemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more Mayo Clinic 26
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Testing effectiveness (Phase 2)Looking for participantsNCT03815890What this trial is testingPre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IOWho this might be right forBreast Cancer The Netherlands Cancer Institute 80
Testing effectiveness (Phase 2)Study completedNCT00861705What this trial is testingPaclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryWho this might be right forMale Breast CarcinomaStage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7+2 more National Cancer Institute (NCI) 454
Testing effectiveness (Phase 2)Study completedNCT00633464What this trial is testingRandomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast CancerWho this might be right forTriple Negative Locally Advanced Non-resectable Breast CancerMetastatic Breast Cancer R-Pharm 79